Document is current
Any future updates will be listed below
-
Authors
Laughon, Barbara E.
Nacy, Carol A.
- License Information
-
More Information
Article History
First Online: 9 March 2017
Competing interests
: C.A.N. is the Founder and CEO of Sequella, Inc., which is the commercial developer of sutezolid and SQ109. B.E.L. declares no competing interests.
